Uses and complications of mitomycin C in ophthalmology. - Wikidata - wikimedia - TriplyDB

Uses and complications of mitomycin C in ophthalmology.

Uses and complications of mitomycin C in ophthalmology.

http://www.wikidata.org/entity/Q36689056

about

Surgery on the Trabecular Meshwork: Histopathological Evidence Potential risk of mitomycin C at high concentrations on peripheral nerve structure.Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferation Target drug delivery system as a new scarring modulation after glaucoma filtration surgery Use of adjunctive mitomycin C in external dacryocystorhinostomy surgery compared with surgery alone in patients with nasolacrimal duct obstruction: A prospective, double-masked, randomized, controlled trial.Scleral resection in chronic central serous chorioretinopathy complicated by exudative retinal detachment.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices.Practice patterns in endoscopic dacryocystorhinostomy: survey of the American Rhinologic Society.5-Fluorouracil versus mitomycin C as adjuncts to conjunctival autograft in preventing pterygium recurrence.Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study.Exogenous Tissue Inhibitor of Metalloproteinase-2 Affects Matrix Metalloproteinase-2 Expression in Conjunctival Filtering Blebs and Bleb Scarring in Rats.

P2860

Q26753170-68CE4B56-8816-4701-8854-7DA597A292F8 Q30431142-69693EEE-D7D9-4BCB-AB17-D667D45832E2 Q34628633-9CBEA8EA-DA8D-40B9-A4BF-5FAE177B4A47 Q35122073-6A3D03FB-EC85-49ED-A80B-13AA2804C6BF Q37667529-39677FFA-F667-4422-874F-B289641BEFD8 Q41051245-7D2E4343-E8A9-4051-AC3E-994F5F7CE8D0 Q41080847-760ADF41-458E-41D9-A7C7-A199ADA5C5D6 Q42943183-361C7DF7-EF61-493E-839E-B987DBA15213 Q46817971-971E4CC9-8136-4680-93F1-A0EB81549DFE Q46874613-CE929C47-607B-4BC7-8F8C-267930381904 Q47148978-3FF32F64-ADB3-447D-8C6F-7254A01C415C Q55465988-25B6A421-7D1A-45CB-9322-B5B786BAB20A

P2860

Uses and complications of mitomycin C in ophthalmology.

http://www.wikidata.org/entity/Q36689056

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Uses and complications of mitomycin C in ophthalmology.

@ast

Uses and complications of mitomycin C in ophthalmology.

@en

type

label

Uses and complications of mitomycin C in ophthalmology.

@ast

Uses and complications of mitomycin C in ophthalmology.

@en

prefLabel

Uses and complications of mitomycin C in ophthalmology.

@ast

Uses and complications of mitomycin C in ophthalmology.

@en

P1433

Q36689056-CCD4BEE2-0684-40F1-BAC5-3D90B5C5C51B

P1476

Q36689056-5D40AFC9-B035-49AC-8F9A-93D651492D78

P2093

Q36689056-1C7696A5-157C-4413-992B-467FE2710D3A

Q36689056-B86F8462-E2BB-41BE-B1D0-49BCAE75D336

P2860

Q36689056-08E43E66-1BD9-433E-82CD-66BCD7C9476F

Q36689056-127DFDB3-18F3-4D5F-8B2D-AD8372F9534A

Q36689056-16BE1891-3609-4E9E-9206-8270750A4726

Q36689056-30A35D1D-45CA-4572-8821-616F46EAA17E

Q36689056-3CC6122C-8E89-4E6E-AD1A-CF723027A7E9

Q36689056-4B993A7B-3AE9-465C-B322-07A520AB852D

Q36689056-4D0F9D5C-7060-48F0-A163-7EE6FD4BB78F

Q36689056-5D6B0C0A-4819-4ACE-A1C5-F8E677C88148

Q36689056-60A28550-4666-4EA9-BE1D-F8B7B84788C8

Q36689056-667A65F3-F849-4822-BA4C-38DA53529E0C

P304

Q36689056-5B9C7A31-F68F-428A-9CC9-4AA4C986FC3E

P31

Q36689056-27767A1E-718B-4474-AAE5-69E4187EB197

P356

Q36689056-17902406-CA2B-4087-BC49-C53E6EA18F98

P407

Q36689056-CEE53C0B-C5C7-4FA9-A0FF-AE45CAD8D63C

P433

Q36689056-5AC4F800-A603-4051-A7BB-ACD5643D1FB5

P478

Q36689056-72E00936-64CA-446C-BA31-C6F96A50E476

P577

Q36689056-A9FC7F32-D3DD-429F-8478-D8D8722D4118

P698

Q36689056-D6746114-A19F-4CD2-9F32-A211F873F564

P356

14740338.6.1.27

P1433

Expert Opinion on Drug Safety

P1476

Uses and complications of mitomycin C in ophthalmology.

@en

P2093

Ali A Mearza

http://www.w3.org/2001/XMLSchema#string

Ioannis M Aslanides

http://www.w3.org/2001/XMLSchema#string

P2860

Serious complications of topical mitomycin-C after pterygium surgery

Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.

Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy.

Quality of vision after laser in situ keratomileusis: influence of dioptric correction and pupil size on visual function.

Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up.

A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy.

Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes.

Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study.

Conditions for balance between lower normal pressure control and hypotony in mitomycin trabeculectomy.

The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy. A prospective, randomized, double-blind trial.

P304

27-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.6.1.27

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17181449

http://www.w3.org/2001/XMLSchema#string